A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 56
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ASIT
Long Form : allergen-specific immunotherapy
No. Year Title Co-occurring Abbreviation
2019 Longitudinal evaluation of immunological responses to allergen-specific immunotherapy in horses with IgE associated dermatological disease, a pilot study. AD, ELISA, IDT, IgE, IgG, VAS
2019 Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells. BCR, HA, IBCs, MS, SAgAIns, SAgAs, T1D
2018 Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy? APCs, T1D
2018 Application of bacterial therapeutic vaccine Immunovac-VP4 in the treatment of pollinosis. IgE
2018 ASIT therapy: advantages and adverse effects. own results and literature data. ---
2018 Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis. RG, SG, SLIT, VAS
2018 Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT. ---
2018 Long-term management of horses with atopic dermatitis in southeastern England: a retrospective questionnaire study of owners' perceptions. IDT
2018 Oral immunotherapy with the ingestion of house dust mite extract in a murine model of allergic asthma. HDM
10  2017 Allergen-loaded strontium-doped hydroxyapatite spheres improve allergen-specific immunotherapy in mice. MDDCs, OVA, SHAS
11  2017 Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitis. EAE, IFA
13  2017 Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. BCR, EAE, HA, MS, PLP
14  2017 Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis. AR, HDMs, PBMCs, SCIT, SLIT, TMS, TNSS
15  2017 The future of immunotherapy for canine atopic dermatitis: a review. CAD
16  2017 [Costs of allergic diseases and saving potential by allergen-specific immunotherapy : A personal assessment]. AR
17  2017 [Placebo effect in clinical trials with allergen-specific immunotherapy with inhalant allergens]. SMS
18  2017 [The clinical efficacy of allergen-specific immunotherapy with water-salt extracts and adjuvant allergens for atopic asthma with household sensitization]. ---
19  2016 Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity. ---
20  2016 Contact allergy in atopic individuals in relation to allergen-specific immunotherapy. AD
21  2016 The effect of allergen-specific immunotherapy on offspring. CI, OR
22  2016 [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis]. CADESI, ILIT
23  2015 Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis. AD, OVA, s.c, sOVA
24  2015 FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy. FoxP3
25  2015 Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy. OVA
26  2015 Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite. AD, HDM, IFN, IL, POEM, POEM, s-IgE, s-IgG4, TGF
27  2015 Long-term efficacy of allergen specific immunotherapy in atopic dermatitis patients in relation to quality of life. AD, DLQI
28  2015 Peptide-based allergen specific immunotherapy for the treatment of allergic disorders. Treg
29  2015 [Immunotherapy effect of ploypeptide vaccine of allergen group 1 from Dermatophagoides farinae on asthma mice]. BALF, SSCC
30  2014 Allergen-specific immunotherapy in horses with insect bite hypersensitivity: a double-blind, randomized, placebo-controlled study. IBH
31  2014 Mammalian-derived respiratory allergens - implications for diagnosis and therapy of individuals allergic to furry animals. ---
32  2013 Antigen specific immunotherapy generates CD27(+) CD35(+) tolerogenic dendritic cells. DC, FA
33  2013 DermAll nanomedicine for allergen-specific immunotherapy. OVA
34  2013 Factors influencing the response to specific immunotherapy for asthma in children aged 5-16 years. AHR, CI
35  2013 Production of a chimeric allergen derived from the major allergen group 1 of house dust mite species in Nicotiana benthamiana. TRBO
36  2013 Upregulated levels of human beta-defensins in patients with seasonal allergic rhinitis after allergen-specific immunotherapy treatment. AMPs, ELISA, HBDs, mRNA, NAL, RT-PCR, SAR
37  2013 Vaccine against autoimmune disease: antigen-specific immunotherapy. ---
38  2012 Allergen-specific immunotherapy for atopic eczema: updated. ---
39  2012 Diminished levels of nasal S100A7 (psoriasin) in seasonal allergic rhinitis: an effect mediated by Th2 cytokines. LPS, NAL, PBMC, SAR
40  2012 Equine atopic skin disease and response to allergen-specific immunotherapy: a retrospective study at the University of California-Davis (1991-2008). CS
41  2012 Total IgE and allergen-specific IgE and IgG antibody levels in sera of atopic dermatitis affected and non-affected Labrador- and Golden retrievers. Ab, CAD, Df
42  2011 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). ---
43  2011 Risk factors for systemic reactions to allergen immunotherapy. CPGs, SLIT
44  2011 The impact of oral versus inhaled glucocorticoids on allergen specific IgE testing in experimentally asthmatic cats. BGA, GCs, IDST
45  2010 [Immunovac-VP4 vaccine used in complex allergen-specific immunotherapy of patients with hay fever]. ---
46  2009 CD-sens: a biological measure of immunological changes stimulated by ASIT. ABA
47  2008 Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy. AHR, BAL, CBPs, CDE
48  2008 Dermatophagoides farinae-specific IgG responses in atopic dogs undergoing allergen-specific immunotherapy with aqueous vaccines. ---
49  2008 Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. PEF
50  2008 [Immunological principles of allergen-specific immune therapy]. ---
51  2007 Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy. ---
52  2006 Feline immunotherapy. ---
53  2005 Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study. LD, mCADESI, SD
54  2005 [Grounds for treatment of patients with infectious-allergic rhinitis with bacterial allergens]. IAR
55  2004 Examination of serum total IgG1 concentration in atopic and non-atopic dogs. IgG1
56  2001 The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy. AD